Drug recall · September 17, 2025
4.2% Sodium Bicarbonate Injection recall
Why: Failed Impurities/Degradation Specifications: out of specification results for arsenic in the impurities tested.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
4.2% Sodium Bicarbonate Injection, USP, 5 mEq/10 mL (0.5 mEq/mL), For Intravenous Use Only, 10 mL Single Dose Vial, Rx Only, Manufactured and Distributed by: Exela Pharma Sciences, LLC, Lenoir, NC 28645 USA, NDC 51754-5012-1 (vial); 51754-5012-4 (carton)
- Lots / codes
Lot # 10004077, Exp. 02/28/2026
- Quantity
- N/A
- Company
- Exela Pharma Sciences LLC, Lenoir, NC
- Distribution
- Nationwide in the USA
- Initiated
- July 30, 2025 · Voluntary: Firm initiated
- Classified
- September 5, 2025
- Reported
- September 17, 2025
- How notified
- Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Sodium bicarbonate
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.